+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid and piroxicam up-regulate MHC antigen expression in rat colonocytes during colon cancer development



Ursodeoxycholic acid and piroxicam up-regulate MHC antigen expression in rat colonocytes during colon cancer development



Gastroenterology 106(4 Suppl. ): A433




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144799

Download citation: RISBibTeXText


Related references

The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. Immunology 83(2): 319-323, 1994

Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. Nutrition and Cancer 60(3): 389-400, 2008

Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Research 63(13): 3517-3523, 2003

Expression of G-protein alpha subunits in normal rat colonocytes, azoxymethane -induced colon tumors, and human colon cancer-derived cell lines. Gastroenterology 108(4 Suppl. ): A954, 1995

High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancy. Plos One 8(5): E64101, 2013

Effect of ursodeoxycholic acid in an experimental colon cancer model FT Efecto del acido ursodeoxicolico en un modelo experimental de cancer de colon. 2007

The effect of eicosanoids on the expression of MHC genes in cultured human colon cancer cells and mouse colonocytes in vivo. Prostaglandins Leukotrienes & Essential Fatty Acids 55(6): 373-378, 1996

Ursodeoxycholic acid protects against experimental colon cancer. Gastroenterology 106(4 Suppl. ): A393, 1994

Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer. Digestive Diseases and Sciences 59(10): 2367-2380, 2014

Effect of ursodeoxycholic acid in an experimental colon cancer model. Revista Espanola de Enfermedades Digestivas 99(9): 491-496, 2007

Chemoprevention of colon cancer by ursodeoxycholic acid a possible mechanism of action. Gastroenterology 108(4 Suppl. ): A463, 1995

Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. Nutrition and Cancer 64(4): 617-626, 2012

Chemoprotective ursodeoxycholic acid, but not chemopromotional cholic acid, prevents the activation of PKC-beta-2 and PKC-zeta in the azoxymethane model of colon cancer. Gastroenterology 108(4 Suppl. ): A550, 1995

Ursodeoxycholic acid alters the expression of p53, BAX, and p21-WAF-1/cip1 in human colon adenocarcinoma cells. Gastroenterology 112(4 Suppl. ): A595, 1997

Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells. International Journal of Cancer 118(3): 532-539, 2005